- 著者
 
          - 
             
             國方 敏夫
             
             河野 恵三
             
             牛尾 慎平
             
             福田 恵温
             
          
 
          
          
          - 出版者
 
          - 公益社団法人 日本薬学会
 
          
          
          - 雑誌
 
          - YAKUGAKU ZASSHI (ISSN:00316903)
 
          
          
          - 巻号頁・発行日
 
          - vol.131, no.11, pp.1667-1674, 2011-11-01 (Released:2011-11-01)
 
          
          
          - 参考文献数
 
          - 30
 
          
          
          - 被引用文献数
 
          - 
             
             1
             
             
             1
             
             
          
        
 
        
        
        We previously reported that oral administration of NK-4, a criptocyanine dye, enhances interleukin (IL)-12-depend- ent interferon (IFN)-γ production by lipopolysaccharide (LPS)-stimulated mouse splenocytes. These findings raised a possibility that NK-4 potentiated IFN-γ production by T cells, natural killer (NK) cells or natural killer T (NKT) cells in response to IL-12 produced by macrophage and dendritic cells. To explore this possibility, we first analyzed percentages of T, NK or NKT cells in splenocytes of mice that were administered NK-4 orally for three days. The percentage of NKT cells in splenocytes from NK-4-treated mice was significantly (p<0.05) increased compared to vehicle-treated mice. When splenocytes were stimulated with α-galactosylceramide (α-GalCer), an NKT cell ligand, IFN-γ production by splenocytes from NK-4-treated mice tended to increase, while no difference in the IL-4 production and proliferation were observed between the vehicle- and NK-4-treated mice. When IFN-γ/IL-4 ratios were calculated in individual mice, the ratios were significantly (p<0.05) elevated in NK-4-treated mice. Furthermore, IL-12 production by α-GalCer-stimulated splenocytes from NK-4-treated mice was also significantly (p<0.05) increased. These results suggest that oral administration of NK-4 increases the population of type I NKT cells with potent IFN-γ-producing activities. Since IL-12 and IFN-γ have been shown to play important roles in anti-tumor immunity as well as in the defence against bacterial infection, our results further imply that NK-4 may provide a potential therapeutic tool in cancer immunotherapy.